Evidence that amphotericin B mediates reactivation of latent Epstein-Barr virus in Hodgkin's lymphoma allowing cytotoxicity by Acyclovir

Yonsei Medical Journal

Volumn 47, Issue 2, 2006, Pages 287-290

  Kast, Richard E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Acyclovir; Amphotericin B; Coley's toxin; Epstein Barr virus; Ganciclovir; Hodgkin's lymphoma; Remission; TNF

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FAMCICLOVIR; GANCICLOVIR; METHOTREXATE; OXYBATE SODIUM; PENCICLOVIR; PREDNISONE; PROCARBAZINE; VALACICLOVIR; VINBLASTINE; VINCRISTINE;

ARTICLE; BREAST CANCER; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL KILLING; COLON CANCER; DRUG CYTOTOXICITY; DRUG SAFETY; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; EVIDENCE BASED MEDICINE; HODGKIN DISEASE; HUMAN; MEDICAL RESEARCH; NASOPHARYNX CARCINOMA; NONHUMAN; PROSTATE CANCER; SEPSIS; VIRUS INFECTION; VIRUS REACTIVATION;

ACYCLOVIR; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; BURKITT LYMPHOMA; DRUG SYNERGISM; GANCICLOVIR; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; REMISSION INDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VIRUS ACTIVATION;

EID: 33646202809     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.2.287     Document Type: Article

References (15)

1. Bang SM, Cheong JW, Yang WI, Hahn JS. An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications. Yonsei Med J 2005;46:425-30.
2. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 1994;64:529-64.
3. Kuppers R, Hansmann ML. The Hodgkin and Reed Sternberg cell. Int J Biochem Cell Biol 2005;37:511-7.
4. Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin's lymphoma. Blood 2004;103:1755-62.
5. Crumpacker CS. Ganciclovir. N Engl J Med 1996;335: 721-9.
6. Faller DV, Mentzer SJ, Perrine SP. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies. Curr Opin Oncol 2001;13:360-7.
7. Feng WH, Hong G, Delecluse HJ, Kenney SC. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J Virol 2004;78:1893-902.
8. Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 2004;96:1691-702.
9. Daibata M, Bandobashi K, Kuroda M, Imai S, Miyoshi I, Taguchi H. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo. J Virol 2005;79:5875-9.
10. Israel BF, Kenney SC. Virally targeted therapies for EBV-associated malignancies. Oncogene 2003;22:5122-30.
11. Neyts J, Sadler R, De Clercq E, Raab-Traub N, Pagano JS. The antiviral agent cidofovir[(S)-1-(3-hydroxy-2- phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res 1998;58:384-8.
12. Razonable RR, Henault M, Lee LN, Laethem C, Johnston PA, Watson HL, et al. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother 2005;49:1617-21.
13. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003;278:37561-8.
14. Murakawa M, Shibuya T, Teshima T, Kudo J, Okamura T, Harada M, et al. Spontaneous remission from acute exacerbation of chronic adult T-cell leukemia. Blut 1990,61:346-9.
15. Malewicz B, Momsen M, Jenkin HM, Borowski E. Potentiation of antiviral activity of acyclovir by polyene macrolide antibiotics. Antimicrob Agents Chemother 1984;25:772-4.